Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Clinical trial NCT05312671 · RECRUITING

Trial details

NCT number: NCT05312671
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Neuroendocrine Carcinoma of Bladder Bladder Cancer Urothelial Carcinoma Bladder

Start date: 2022-06-27
Primary completion: 2027-10-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.